Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) — Cash Flow-to-Debt Ratio
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) has a Cash Flow-to-Debt Ratio of 0.28x as of September 2024, meaning its operating cash flow of TL33.37 Million could theoretically repay 0% of its total liabilities (TL120.48 Million) in one year. See Oncosem Onkolojik Sistemler Sanayi ve Ti free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Cash Flow-to-Debt Ratio (2020–2023)
Historical debt coverage capacity for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. across 4 annual periods. Also explore Oncosem Onkolojik Sistemler Sanayi ve Ti annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2020–2023)
Year-by-year debt coverage analysis for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.. For market capitalisation and broader financial context, see market value of Oncosem Onkolojik Sistemler Sanayi ve Ti.
| Year | CF-to-Debt Ratio | Operating CF (TRY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2023 | -0.36x | TL-38.10 Million | TL106.61 Million | ▼ -185.1% |
| 2022 | 0.42x | TL52.69 Million | TL125.50 Million | ▼ -58.8% |
| 2021 | 1.02x | TL51.68 Million | TL50.75 Million | ▲ +194.4% |
| 2020 | 0.35x | TL19.41 Million | TL56.11 Million | — |